Atlas Trials

26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

Clinical trial NCT00624052 · COMPLETED

Trial details

NCT number
NCT00624052
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2008-03-01
Primary completion
2009-06-01
Enrollment
838

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.